← Holders
Foresite Capital Management V, LLC
What Foresite Capital Management V, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1792206 · Filed Nov 16, 2026
- Positions
- 9
- Reported value
- $289.1M
- Opened
- 1
- Closed
- 1
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$108.7M6 positions
- Dec 31, 2025$164.4M7 positions
- Mar 31, 2026$271M9 positions
- Jun 30, 2026$362.2M9 positions
- Sep 30, 2026$289.1M9 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
CGONCG Oncology, Inc. | 1.1M | ±0% | $76.5M | 26.5% |
LTGOLatigo Biotherapeutics, Inc. | 3.6M | New | $59.5M | 20.6% |
ALMSAlumis Inc. | 5.9M | ±0% | $43.6M | 15.1% |
HIMSHims & Hers Health, Inc. | 883.8K | +19.7% | $26.3M | 9.1% |
IRONDisc Medicine, Inc. | 374.1K | ±0% | $24.5M | 8.5% |
PHVSPharvaris N.V. | 664.1K | ±0% | $21.1M | 7.3% |
ODTXOdyssey Therapeutics, Inc. | 729.6K | +2.3% | $16.2M | 5.6% |
NRIXNurix Therapeutics, Inc. | 458.7K | +73.1% | $10.9M | 3.8% |
EIKNEikon Therapeutics, Inc. | 1.3M | ±0% | $10.6M | 3.7% |